Search - tctmd.com

Displaying 201 - 220 of 463

Sort: Relevancy | Date

News Daily News

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

L.A. McKeown

June 09, 2022

News Conference News EAS 2022

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Michael O'Riordan

May 26, 2022

News Conference News EuroPCR 2022

Registry Data Hint at MACE Benefit With Renal Denervation

Michael O'Riordan

May 17, 2022

Presentation EuroPCR 2022

Patient-Level Pooled Analysis of Ultrasound RDN in RADIANCE-HTN SOLO and TRIO

Presenter: Ajay J. Kirtane, Michel Azizi

May 17, 2022

News Daily News

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Michael O'Riordan

May 09, 2022

News Conference News HRS 2022

Intensive BP Control May Stave Off LV Conduction Disease: SPRINT

Todd Neale

May 02, 2022

News Daily News

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

Shelley Wood

April 26, 2022

Presentation ARCH 2022

Current Status and Future of Renal Denervation for Hypertension

Presenter: Tim A. Fischell

April 23, 2022

News Daily News

Statin Use, at Any Dose, Not Linked to Excess Dementia Risk in FH

Yael L. Maxwell

April 22, 2022

News Conference News ACC 2022

POISE-3: Two Perioperative BP Strategies Give Similar Results in Noncardiac Surgery

Todd Neale

April 06, 2022

Presentation ACC 2022

Long Term Efficacy and Safety of Renal Denervation on Blood Pressure in Patients on Antihypertension Medications: 3-Year Outcomes from the SPYRAL HTN-ON MED Trial

Presenter: Felix Mahfoud

April 04, 2022

News Conference News ACC 2022

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

Michael O'Riordan

April 02, 2022

News Conference News ACC 2022

POISE-3: Tranexamic Acid Stems Bleeding During Noncardiac Surgery

Todd Neale

April 02, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

More Evidence Links Breast Arterial Calcification and CVD Risk

News Daily News

Acetaminophen Raises BP, Just Like NSAIDs Do, in Patients With Hypertension

Yael L. Maxwell

February 09, 2022

News Daily News

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Michael O'Riordan

January 25, 2022

News Daily News

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

Michael O'Riordan

December 23, 2021

News Daily News

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

Yael L. Maxwell

December 14, 2021

News Conference News AHA 2021

ApoB Gains Ground as Best Lipid Predictor of MI Risk

Michael O'Riordan

November 22, 2021

Advertisement

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Registry Data Hint at MACE Benefit With Renal Denervation

Patient-Level Pooled Analysis of Ultrasound RDN in RADIANCE-HTN SOLO and TRIO

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Intensive BP Control May Stave Off LV Conduction Disease: SPRINT

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

Current Status and Future of Renal Denervation for Hypertension

Statin Use, at Any Dose, Not Linked to Excess Dementia Risk in FH

POISE-3: Two Perioperative BP Strategies Give Similar Results in Noncardiac Surgery

Long Term Efficacy and Safety of Renal Denervation on Blood Pressure in Patients on Antihypertension Medications: 3-Year Outcomes from the SPYRAL HTN-ON MED Trial

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

POISE-3: Tranexamic Acid Stems Bleeding During Noncardiac Surgery

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

More Evidence Links Breast Arterial Calcification and CVD Risk

Acetaminophen Raises BP, Just Like NSAIDs Do, in Patients With Hypertension

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

ApoB Gains Ground as Best Lipid Predictor of MI Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content